Nifty

:

24334.55

Sensex

:

77656.09

115.50 (0.48%)
286.98 (0.37%)

Login

Nifty
Sensex

:
:

24334.55
77656.09

115.50 (0.48%)
286.98 (0.37%)

Kimia Biosciences Ltd.

Pharmaceuticals & Drugs

Rating :

61/99

BSE: 530313 | NSE: Not Listed

Watchlist

NSE BSE

Open
High
Low
Previous Close

N/A
N/A
N/A
N/A

Volume
Traded Value (lacs)
52 Week High
52 Week Low

N/A
N/A
N/A
N/A

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

131.96
18.37
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

165.76
N/A
7.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

90.39
-2.17
-2.55

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
19.30
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
13.51
-

P:E (Median)

8 Years
5 Years
3 Years

15.57
-
15.70

P:BV (Average)

8 Years
5 Years
3 Years

87.58
110.83
175.04

EV:EBITDA (Average)

8 Years
5 Years
3 Years

36.01
43.88
21.24

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 20.72 23.58 -12.13% 27.20 38.24 -28.87% 30.10 30.10 0.00% 34.00 28.18 20.65%
Expenses 18.38 21.06 -12.73% 24.54 30.06 -18.36% 23.54 25.10 -6.22% 31.48 24.81 26.88%
EBITDA 2.35 2.53 -7.11% 2.66 8.18 -67.48% 6.56 5.00 31.20% 2.52 3.37 -25.22%
EBIDTM 11.32% 10.71% 9.80% 21.39% 21.78% 16.60% 7.41% 11.96%
Other Income 0.08 0.85 -90.59% 1.01 0.44 129.55% 0.10 0.42 -76.19% -0.33 0.37 -
Interest 0.83 1.75 -52.57% 0.75 1.40 -46.43% 0.75 1.01 -25.74% 0.27 1.04 -74.04%
Depreciation 1.11 0.94 18.09% 1.16 0.88 31.82% 0.85 0.82 3.66% 0.97 0.79 22.78%
PBT 0.49 0.69 -28.99% 1.76 6.34 -72.24% 5.05 3.60 40.28% 0.95 1.92 -50.52%
Tax 0.13 0.09 44.44% 1.39 4.35 -68.05% -0.39 -0.97 - -0.07 0.30 -
PAT 0.36 0.60 -40.00% 0.37 1.99 -81.41% 5.44 4.57 19.04% 1.02 1.61 -36.65%
PATM 1.71% 2.56% 1.37% 5.21% 18.08% 15.18% 2.99% 5.73%
EPS 0.08 0.13 -38.46% 0.08 0.42 -80.95% 1.15 0.97 18.56% 0.21 0.34 -38.24%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 112.02 118.92 104.88 128.52 124.90 132.71 106.29 93.92 76.31 1.46 0.19 Net Sales Growth -6.73% 13.39% -18.39% 2.90% -5.89% 24.86% 13.17% 23.08% 5126.71% 668.42% Cost Of Goods Sold 67.19 70.87 75.26 96.03 92.26 96.86 80.24 71.08 59.32 0.35 0.08 Gross Profit 44.83 48.05 29.62 32.48 32.64 35.86 26.04 22.84 16.99 1.11 0.11 GP Margin 40.02% 40.41% 28.24% 25.27% 26.13% 27.02% 24.50% 24.32% 22.26% 76.03% 57.89% Total Expenditure 97.94 98.67 105.36 133.61 124.27 124.33 101.83 88.34 73.83 2.44 3.57 Power & Fuel Cost - 5.66 5.25 7.29 6.54 4.54 3.21 2.54 1.85 0.17 0.31 % Of Sales - 4.76% 5.01% 5.67% 5.24% 3.42% 3.02% 2.70% 2.42% 11.64% 163.16% Employee Cost - 13.68 15.15 16.40 15.08 14.09 10.80 8.82 7.58 0.83 2.13 % Of Sales - 11.50% 14.45% 12.76% 12.07% 10.62% 10.16% 9.39% 9.93% 56.85% 1121.05% Manufacturing Exp. - 2.11 2.59 3.83 3.62 4.07 2.74 1.22 0.95 0.17 0.17 % Of Sales - 1.77% 2.47% 2.98% 2.90% 3.07% 2.58% 1.30% 1.24% 11.64% 89.47% General & Admin Exp. - 4.05 4.33 3.68 3.14 2.30 2.16 1.76 1.92 0.60 0.36 % Of Sales - 3.41% 4.13% 2.86% 2.51% 1.73% 2.03% 1.87% 2.52% 41.10% 189.47% Selling & Distn. Exp. - 2.12 2.23 2.47 1.80 1.15 0.94 0.57 0.40 0.01 0.01 % Of Sales - 1.78% 2.13% 1.92% 1.44% 0.87% 0.88% 0.61% 0.52% 0.68% 5.26% Miscellaneous Exp. - 0.19 0.55 3.92 1.82 1.33 1.74 2.36 1.82 0.30 0.01 % Of Sales - 0.16% 0.52% 3.05% 1.46% 1.00% 1.64% 2.51% 2.39% 20.55% 268.42% EBITDA 14.09 20.25 -0.48 -5.09 0.63 8.38 4.46 5.58 2.48 -0.98 -3.38 EBITDA Margin 12.58% 17.03% -0.46% -3.96% 0.50% 6.31% 4.20% 5.94% 3.25% -67.12% -1778.95% Other Income 0.86 1.32 1.64 1.33 0.93 2.46 0.96 1.33 0.86 0.59 0.19 Interest 2.60 4.56 5.05 4.25 3.64 3.39 2.53 2.00 0.58 0.27 0.56 Depreciation 4.09 3.38 3.29 3.33 2.94 1.91 1.66 1.10 1.14 0.35 0.29 PBT 8.25 13.63 -7.18 -11.34 -5.02 5.53 1.23 3.81 1.60 -1.01 -4.04 Tax 1.06 4.02 -1.88 -3.04 -1.32 0.43 -0.15 -0.05 -0.06 -0.08 0.01 Tax Rate 12.85% 29.49% 26.18% 24.54% 26.29% 7.78% -12.20% -1.31% -3.75% 7.92% -0.25% PAT 7.19 9.61 -5.31 -9.35 -3.70 5.10 1.38 3.86 1.67 -0.93 -4.05 PAT before Minority Interest 7.19 9.61 -5.31 -9.35 -3.70 5.10 1.38 3.86 1.67 -0.93 -4.05 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.42% 8.08% -5.06% -7.28% -2.96% 3.84% 1.30% 4.11% 2.19% -63.70% -2131.58% PAT Growth -18.02% - - - - 269.57% -64.25% 131.14% - - EPS 1.52 2.03 -1.12 -1.98 -0.78 1.08 0.29 0.82 0.35 -0.20 -0.86

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 9.97 0.33 5.46 14.89 18.44 13.37 6.11 2.29 -4.61 -3.88 Share Capital 4.73 4.73 4.73 4.73 4.73 4.73 2.11 2.11 7.38 7.38 Total Reserves 5.23 -4.40 0.73 10.16 13.71 8.64 2.03 -1.79 -12.00 -11.26 Non-Current Liabilities 17.66 24.41 35.49 31.89 37.28 33.66 28.85 25.27 9.12 7.30 Secured Loans 3.13 4.44 6.45 3.89 9.75 8.70 0.62 0.28 0.00 2.91 Unsecured Loans 7.24 16.97 24.39 20.55 18.60 15.61 23.49 24.45 8.83 3.84 Long Term Provisions 1.60 1.45 1.45 1.12 1.17 0.88 0.64 0.49 0.29 0.27 Current Liabilities 81.83 69.44 76.40 61.80 50.95 38.63 30.44 30.69 7.24 0.68 Trade Payables 50.49 39.99 46.59 40.21 30.79 26.56 17.66 19.50 0.49 0.02 Other Current Liabilities 11.60 9.63 9.95 6.73 6.98 5.71 7.33 6.62 6.69 0.67 Short Term Borrowings 19.64 19.79 19.83 14.81 13.13 6.32 5.42 4.56 0.00 0.00 Short Term Provisions 0.10 0.03 0.03 0.05 0.05 0.04 0.03 0.01 0.06 0.00 Total Liabilities 109.46 94.18 117.35 108.58 106.67 85.66 65.40 58.25 11.75 4.10 Net Block 33.28 31.85 33.63 35.23 28.37 17.84 16.15 12.90 6.66 3.20 Gross Block 52.24 47.43 45.93 44.19 34.45 22.32 19.09 14.74 6.97 11.55 Accumulated Depreciation 18.96 15.59 12.30 8.96 6.08 4.47 2.94 1.84 0.31 8.34 Non Current Assets 34.16 32.77 34.60 35.51 34.83 24.72 17.85 15.49 9.86 3.50 Capital Work in Progress 0.00 0.58 0.61 0.00 5.77 5.74 1.53 2.48 3.07 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.84 0.34 0.24 0.20 0.66 1.13 0.17 0.12 0.13 0.14 Other Non Current Assets 0.03 0.02 0.12 0.08 0.03 0.00 0.00 0.00 0.00 0.15 Current Assets 75.29 61.41 82.75 73.07 70.14 60.95 47.55 42.76 1.88 0.61 Current Investments 0.00 0.00 0.06 0.06 0.06 0.42 0.01 0.00 0.00 0.00 Inventories 34.58 30.80 48.23 37.02 23.69 20.31 16.10 9.59 0.59 0.07 Sundry Debtors 36.75 27.55 30.59 30.20 41.77 37.33 29.12 29.50 0.08 0.09 Cash & Bank 0.68 0.53 0.50 0.52 1.67 0.77 1.26 2.03 0.07 0.01 Other Current Assets 3.28 0.96 1.84 1.02 2.96 2.12 1.05 1.64 1.14 0.43 Short Term Loans & Adv. 2.17 1.56 1.53 4.26 2.29 1.60 0.82 1.39 0.44 0.40 Net Current Assets -6.53 -8.03 6.35 11.27 19.19 22.32 17.11 12.07 -5.36 -0.08 Total Assets 109.45 94.18 117.35 108.58 104.97 85.67 65.40 58.25 11.74 4.11

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 21.31 14.53 -6.77 8.00 5.97 0.31 -2.65 -7.09 -0.74 -5.99 PBT 13.63 -7.18 -12.39 -5.02 5.53 1.23 3.81 1.60 -1.01 -4.04 Adjustment 6.82 7.76 7.60 5.96 3.57 3.81 1.35 1.36 0.77 0.86 Changes in Working Capital 0.80 13.94 -2.00 7.13 -3.18 -4.80 -7.65 -10.06 -0.47 -2.80 Cash after chg. in Working capital 21.26 14.51 -6.78 8.07 5.92 0.24 -2.49 -7.10 -0.70 -5.99 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.05 0.03 0.01 -0.07 0.04 0.07 -0.16 0.01 -0.04 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.70 -1.49 -2.80 -0.71 -13.60 -8.63 -2.22 -2.36 -6.23 -0.10 Net Fixed Assets -4.23 -1.47 -2.35 -3.97 -12.16 -7.44 -3.40 -7.18 1.51 0.35 Net Investments 0.00 0.06 0.00 0.00 0.36 -0.41 -0.01 0.00 0.00 0.00 Others -0.47 -0.08 -0.45 3.26 -1.80 -0.78 1.19 4.82 -7.74 -0.45 Cash from Financing Activity -16.55 -13.07 9.54 -7.67 7.99 8.46 4.42 9.91 7.01 6.09 Net Cash Inflow / Outflow 0.06 -0.03 -0.03 -0.38 0.35 0.14 -0.46 0.46 0.04 0.01 Opening Cash & Equivalents 0.15 0.18 0.20 0.59 0.23 0.09 0.55 0.09 0.01 0.00 Closing Cash & Equivalent 0.21 0.15 0.18 0.20 0.59 0.23 0.09 0.55 0.05 0.01

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 2.11 0.07 1.15 3.15 3.90 2.86 2.39 -0.23 -6.25 -5.25 ROA 9.44% -5.02% -8.28% -3.44% 5.31% 1.83% 6.24% 4.76% -11.72% -92.83% ROE 186.70% -183.25% -91.91% -22.22% 32.19% 16.47% 243.83% 0.00% 0.00% 0.00% ROCE 42.18% -4.18% -14.30% -2.32% 16.13% 8.94% 16.94% 11.83% -18.30% -216.82% Fixed Asset Turnover 2.39 2.25 2.85 3.18 4.68 5.13 5.55 7.04 0.16 0.02 Receivable days 98.68 101.18 86.33 105.16 108.76 114.09 113.91 70.58 20.80 345.52 Inventory Days 100.34 137.54 121.06 88.70 60.51 62.52 49.92 24.31 83.49 143.48 Payable days 233.00 209.95 164.94 140.43 108.06 100.58 79.39 49.73 48.83 64.75 Cash Conversion Cycle -33.97 28.76 42.45 53.43 61.21 76.04 84.43 45.15 55.46 424.25 Total Debt/Equity 3.27 131.12 9.69 2.73 2.44 2.54 7.39 91.22 -2.12 -1.74 Interest Cover 3.99 -0.42 -1.92 -0.38 2.63 1.48 2.91 3.76 -2.74 -6.26

Top Investors:

anish kumar aggarwal

Annual Reports:

News Update:

Kimia Biosciences - Quarterly Results
11th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback